ProcedureFundamentalsOPCS-4 S60โ€“S62

Skin biopsy techniques

Punch biopsy; shave biopsy; incisional biopsy; excisional biopsy; saucerisation

Skin biopsy is the foundation of skin-oncology diagnosis. The four techniques โ€” punch, shave, incisional and excisional โ€” each have specific indications and pitfalls. The wrong technique on the wrong lesion is one of the commonest avoidable causes of diagnostic delay and management error: a partial shave of a pigmented lesion that turns out to be melanoma destroys Breslow accuracy, while a punch through the centre of a BCC may underestimate subtype. Choose the technique by the question being asked of the pathology, the lesion's likely diagnosis, the patient's anatomy and the cosmetic and surgical consequences of the biopsy and any subsequent definitive procedure.

CurrentLast reviewed 15 May 2026

Punch biopsy

  • Indication โ€” inflammatory dermatoses, suspected non-melanoma skin cancer for subtyping, large lesions where representative sampling is acceptable.
  • 3โ€“4 mm punch most commonly used; 6 mm where adequate dermis is needed (e.g. panniculitis).
  • Local anaesthesia with 1% lidocaine + adrenaline 1:200 000 (avoid digits and end-arteries โ€” use plain lidocaine).
  • Skin tensioned perpendicular to relaxed skin tension lines so the resulting defect is elliptical and easier to close.
  • Specimen handled by the deep edge with toothed forceps โ€” avoid crush of the diagnostic surface.
  • Closure method depends on size, site and tension; small trunk punches can be left to heal by secondary intention.
  • Do not punch the centre of a pigmented lesion suspicious for melanoma โ€” depth assessment will be lost. Use excisional biopsy.

Shave biopsy

  • Indication โ€” clearly benign exophytic lesions (seborrhoeic keratoses, naevi for cosmesis), suspected superficial BCC for subtyping, AK with diagnostic uncertainty.
  • Contraindication โ€” any pigmented lesion where melanoma is plausible (Breslow depth lost).
  • Use 15-blade scalpel or a flexible razor blade.
  • Saucerisation (deeper shave) is used for some BCC subtyping and superficial cSCC; depth must allow assessment of the dermis.
  • Haemostasis with aluminium chloride, ferric subsulphate or light electrodesiccation.
  • Heal by secondary intention; outcome depends on site (concave better than convex).

Incisional biopsy

  • Indication โ€” large lesions where excision would cause unacceptable morbidity before histology, suspected inflammatory or infiltrative process, lymphoma, suspected sarcoma.
  • Take a longitudinal ellipse oriented along the future definitive excision axis so the scar can be re-excised within the definitive specimen.
  • Include lesion-skin junction and adequate dermis ยฑ subcutis.
  • For suspected sarcoma the biopsy should be discussed with the regional sarcoma MDT before sampling โ€” incorrectly placed biopsies can mandate larger definitive excisions.

Excisional biopsy

  • Indication โ€” pigmented lesions suspicious for melanoma; small atypical lesions where complete histology is required.
  • 2 mm peripheral margin recommended for suspected melanoma (NICE NG14 ยง1.3) โ€” preserves Breslow accuracy and avoids transection.
  • Cuff of subcutaneous fat at the deep margin is essential.
  • Orient the long axis along relaxed skin tension lines unless re-excision likely to require a specific axis (e.g. lower limb โ€” longitudinal).
  • Mark the specimen for orientation (suture at 12 o'clock) where re-excision of an asymmetric margin may be planned.
  • Send formalin-fixed, with brief clinical history and a precise anatomical location on the request slip.

Pitfalls and orientation

  • Pigmented lesion + shave biopsy = diagnostic disaster if melanoma โ€” always excisional.
  • Document the biopsy site photographically โ€” patients often cannot identify it themselves at follow-up.
  • "Site marking" with a sterile pen, suture-on-skin photograph, or a triangulating photograph relative to a landmark prevents wrong-site wide excision.
  • Specimen orientation โ€” suture or ink a margin only where it would influence re-excision of a single involved margin; over-orientation creates pathology confusion.
  • Always include patient identifiers and clinical history on the request form; "?BCC" is inadequate โ€” provide age, immune status, prior cancers, anatomical site.

References

  1. Pickett H. Shave and punch biopsy for skin lesions. Am Fam Physician; 2011;84:995โ€“1002.
  2. NICE NG14. Melanoma: assessment and management. London: NICE; 2015 (updated 27 July 2022).
  3. Keohane SG et al. British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020. Br J Dermatol. 2021;184(3):401-414.
  4. Nasr I, McGrath EJ, Harwood CA et al. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021. Br J Dermatol. 2021;185(5):899-920.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.